209 related articles for article (PubMed ID: 21354054)
21. [Correlations of S100A4 and MMP9 expressions to infiltration, metastasis and prognosis of non-small cell lung cancer].
Chen XL; Wang LC; Zhang WG; Chen XY; Sun ZM
Nan Fang Yi Ke Da Xue Xue Bao; 2008 Jul; 28(7):1254-8. PubMed ID: 18676277
[TBL] [Abstract][Full Text] [Related]
22. Prognostic value of cytoplasmic expression of S100A4 protein in endometrial carcinoma.
Chong HI; Lee JH; Yoon MS; Suh DS; Kim K; Kim JY; Choi KU
Oncol Rep; 2014 Jun; 31(6):2701-7. PubMed ID: 24756855
[TBL] [Abstract][Full Text] [Related]
23. [Nuclear expression of S100A4 is associated with lymph node metastasis in gastric carcinoma].
Zhong XY; Zhang LH; Jia SQ; Shi T; DU H; Hu Y; Zhang GG; Lu AP; Li JY; Ji JF
Zhonghua Wei Chang Wai Ke Za Zhi; 2007 Sep; 10(5):454-7. PubMed ID: 17851788
[TBL] [Abstract][Full Text] [Related]
24. S100A4 expression and prognosis of gastric cancer: a meta-analysis.
Wang Y; Zhou LB; Li XH
Genet Mol Res; 2014 Dec; 13(4):10398-403. PubMed ID: 25511023
[TBL] [Abstract][Full Text] [Related]
25. Correlation between expression of S100A4 and VEGF-C, and lymph node metastasis and prognosis in gastric carcinoma.
Feng LZ; Zheng XY; Zhou LX; Fu B; Yu YW; Lu SC; Cao NS
J Int Med Res; 2011; 39(4):1333-43. PubMed ID: 21986134
[TBL] [Abstract][Full Text] [Related]
26. Clinicopathologic significance of S100A4 expression in osteosarcoma.
Cao CM; Yang FX; Wang PL; Yang QX; Sun XR
Eur Rev Med Pharmacol Sci; 2014; 18(6):833-9. PubMed ID: 24706307
[TBL] [Abstract][Full Text] [Related]
27. Clinical significance of E-cadherin, β-catenin, vimentin and S100A4 expression in completely resected squamous cell lung carcinoma.
Zhang H; Liu J; Yue D; Gao L; Wang D; Zhang H; Wang C
J Clin Pathol; 2013 Nov; 66(11):937-45. PubMed ID: 23853314
[TBL] [Abstract][Full Text] [Related]
28. Overexpression of S100A4 is closely associated with progression of colorectal cancer.
Cho YG; Kim CJ; Nam SW; Yoon SH; Lee SH; Yoo NJ; Lee JY; Park WS
World J Gastroenterol; 2005 Aug; 11(31):4852-6. PubMed ID: 16097057
[TBL] [Abstract][Full Text] [Related]
29. Intervening in β-catenin signaling by sulindac inhibits S100A4-dependent colon cancer metastasis.
Stein U; Arlt F; Smith J; Sack U; Herrmann P; Walther W; Lemm M; Fichtner I; Shoemaker RH; Schlag PM
Neoplasia; 2011 Feb; 13(2):131-44. PubMed ID: 21403839
[TBL] [Abstract][Full Text] [Related]
30. [Expressions of nm23, P53 and S100A4 proteins and their relationships with metastasis potential in gastric carcinoma].
Yu GZ; Wang JJ; Chen Y; Ni CR; Zhu MH
Zhonghua Wei Chang Wai Ke Za Zhi; 2006 Mar; 9(2):165-9. PubMed ID: 16555162
[TBL] [Abstract][Full Text] [Related]
31. Combined expression of S100A4 and Annexin A2 predicts disease progression and overall survival in patients with urothelial carcinoma.
Zhang Q; Zhao Z; Ma Y; Wang H; Ma J; He X; Zhang D
Urol Oncol; 2014 Aug; 32(6):798-805. PubMed ID: 24968947
[TBL] [Abstract][Full Text] [Related]
32. Clinicopathological and prognostic value of S100A4 expression in gastric cancer: a meta-analysis.
Ling Z; Li R
Int J Biol Markers; 2014 Jun; 29(2):e99-e111. PubMed ID: 24242292
[TBL] [Abstract][Full Text] [Related]
33. Increased expressions of SATB1 and S100A4 are associated with poor prognosis in human colorectal carcinoma.
Niu Y; Wang L; Cheng C; Du C; Lu X; Wang G; Liu J
APMIS; 2015 Feb; 123(2):93-101. PubMed ID: 25257341
[TBL] [Abstract][Full Text] [Related]
34. Metastasis-associated protein S100A4--a potential prognostic marker for colorectal cancer.
Hemandas AK; Salto-Tellez M; Maricar SH; Leong AF; Leow CK
J Surg Oncol; 2006 May; 93(6):498-503. PubMed ID: 16615153
[TBL] [Abstract][Full Text] [Related]
35. Expression of protein S100A4 is a predictor of recurrence in colorectal cancer.
Kwak JM; Lee HJ; Kim SH; Kim HK; Mok YJ; Park YT; Choi JS; Moon HY
World J Gastroenterol; 2010 Aug; 16(31):3897-904. PubMed ID: 20712050
[TBL] [Abstract][Full Text] [Related]
36. Overexpression of S100A4 is closely related to the aggressiveness of gastric cancer.
Cho YG; Nam SW; Kim TY; Kim YS; Kim CJ; Park JY; Lee JH; Kim HS; Lee JW; Park CH; Song YH; Lee SH; Yoo NJ; Lee JY; Park WS
APMIS; 2003 May; 111(5):539-45. PubMed ID: 12887505
[TBL] [Abstract][Full Text] [Related]
37. S100A4 expression is a prognostic indicator in small intestine adenocarcinoma.
Roh J; Knight S; Chung JY; Eo SH; Goggins M; Kim J; Cho H; Yu E; Hong SM
J Clin Pathol; 2014 Mar; 67(3):216-21. PubMed ID: 24062356
[TBL] [Abstract][Full Text] [Related]
38. Expression of S100A4 and Met: potential predictors for metastasis and survival in early-stage breast cancer.
Lee WY; Su WC; Lin PW; Guo HR; Chang TW; Chen HH
Oncology; 2004; 66(6):429-38. PubMed ID: 15452371
[TBL] [Abstract][Full Text] [Related]
39. Expression of S100A6 and S100A4 in matched samples of human colorectal mucosa, primary colorectal adenocarcinomas and liver metastases.
Komatsu K; Murata K; Kameyama M; Ayaki M; Mukai M; Ishiguro S; Miyoshi J; Tatsuta M; Inoue M; Nakamura H
Oncology; 2002; 63(2):192-200. PubMed ID: 12239456
[TBL] [Abstract][Full Text] [Related]
40. Expression and prognostic significance of CEACAM6, ITGB1, and CYR61 in peripheral blood of patients with gastric cancer.
Zhao ZS; Li L; Wang HJ; Wang YY
J Surg Oncol; 2011 Oct; 104(5):525-9. PubMed ID: 21618249
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
